Diabetes insipidus epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
The prevalence of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide. The prevalence and incidence of both central and nephrogenic DI does not vary by gender. Similarly, no significant racial predilection in prevalence has been observed. With both central and nephrogenic diabetes inispidus, inherited causes account for approximately 1-2% of all cases. The incidence of nephrogenic diabetes insipidus caused by AQP2 mutations is about 1 in 20 million births.
Epidemiology and Demographics
Prevalence
The prevalence of diabetes insipidus is estimated to be 3 cases per 100,000 individuals worldwide.[1]
Incidence
The incidence of diabetes insipidus is 1 in 20 million births for nephrogenic diabetes insipidus caused by AQP2 mutations.[1]
Case Fatality Rate
The case-fatality rate of diabetes insipidus is unknown.
Age
Diabetes insipidus has been identified in all age groups from infancy to adulthood.
Gender
The prevalence and incidence of both central and nephrogenic diabetes insipidus does not vary by gender.[1]
Race
There is no racial predilection for diabetes insipidus.
Developed countries
Incidence, prevalence, and geographical distribution of both central diabetes insipidus and nephrogenic diabetes insipidus does not vary.
Developing countries
Incidence, prevalence, and geographical distribution of both central diabetes insipidus and nephrogenic diabetes insipidus does not vary.
References
- ↑ 1.0 1.1 1.2 Verkman AS (2012). “Aquaporins in clinical medicine”. Annu. Rev. Med. 63: 303–16. doi:10.1146/annurev-med-043010-193843. PMC 3319404. PMID 22248325.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH